EBANO study: Clinical characteristics, treatment patterns and survival results in patients with locally advanced/ metastatic urothelial carcinoma (la/mUC) in northern Spain

被引：1
|
作者：
Fernandez-Rodriguez, R. [1 ]
Sagastibelza, N. [2 ]
Pujol Obis, E. [3 ]
Lainez Milagro, N. [4 ]
Sanchez-Escribano, R. [5 ]
Martinez Kareaga, M. [6 ]
Verdun Aguilar, J. A. [7 ]
Arruti Ibarbia, M. [8 ]
Pumares Gonzalez, M. [9 ]
De Portugal Fernandez del Rivero, T. [10 ]
Lacalle, A. [11 ]
Gil Arnaiz, I. [12 ]
Pereira-Elorrieta, A. [13 ]
Duran Martinez, I. [14 ]
机构：
[1] Hosp Univ Cruces, Med Oncol, Baracaldo, Spain
[2] Hosp Donostia, Dept Med Oncol, San Sebastian, Spain
[3] Hosp Clin Univ Lozano Blesa, Med Oncol, Zaragoza, Spain
[4] Hosp Navarra, Med Oncol, Pamplona, Spain
[5] Univ Clin Hosp Valladolid, Med Oncol, Valladolid, Spain
[6] HUA Hosp Univ Araba Txagorritxu, Med Oncol, Vitoria, Spain
[7] Hosp Comarcal Alcaniz, Oncol, Alcaniz, Spain
[8] Hosp Galdakao Usansolo, Med Oncol, Galdakao, Spain
[9] Hosp Univ Burgos HUBU, Med Oncol, Burgos, Spain
[10] Hosp Prov Rodriguez Chamorro, Dept Oncol, Zamora, Spain
[11] Hosp San Pedro, Med Oncol, Logrono, Spain
[12] Hosp Reina Sofia, Med Oncol, Tudela, Spain
[13] IDIVAL Inst Invest Sanitaria Valdecilla, Oncol, Santander, Spain
[14] HUMV Hosp Univ Marques de Valdecilla, Dept Despacho 271, Santander, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2382P
引用
收藏
页码：S1213 / S1213
页数：1
相关论文
共 50 条
  • [41] Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma
    Martini, Alberto
    Fallara, Giuseppe
    Ploussard, Guillaume
    Pradere, Benjamin
    CURRENT OPINION IN UROLOGY, 2022, 32 (05) : 500 - 503
  • [42] Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis
    Hepp, Zsolt
    Shah, Sonali N.
    Smoyer, Karen
    Vadagam, Pratyusha
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (02): : 240 - 255
  • [43] Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma Results of a Large Phase 2 Study
    Vaughn, David J.
    Srinivas, Sandy
    Stadler, Walter M.
    Pili, Roberto
    Petrylak, Daniel
    Sternberg, Cora N.
    Smith, David C.
    Ringuette, Sarah
    de Wit, Edwin
    Pautret, Virginie
    George, Claude
    CANCER, 2009, 115 (18) : 4110 - 4117
  • [44] Age and other criteria influencing nontreatment of patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a physician survey in five European countries (Eu5)
    Gupta, Shilpa
    Powles, Thomas
    Kearney, Mairead
    Panattoni, Laura
    Land, Natalie
    Flottemesch, Thomas
    Sullivan, Patrick
    Kirker, Melissa
    Bharmal, Murtuza
    Guenther, Silke
    Costa, Nuno
    Grande, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] The potential of transcriptomic profiling to predict immune-checkpoint inhibitor (ICIs) response in locally advanced (La) and metastatic urothelial carcinoma (mUC).
    Caramelo, Belen
    Munoz Unceta, Nerea
    Freire, Javier
    Varela, Ignacio
    Martin, David
    Del Carmen, Sofia
    Azueta, Ainara
    Diaz, Pilar
    Garcia-Berbel, Pilar
    Sagastibelza Marinelarena, Naiara
    Rey-Cardenas, Macarena
    Castellano, Daniel
    Climent, Miguel Angel
    Puente, Javier
    Irure, Juan
    Revuelta, Laura
    Genre, Fernanda
    Cacho, Diego
    Gomez, Javier
    Duran, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 668 - 668
  • [46] Study EV-103: Update on durability results and long term outcome of enfortumab vedotin plus pembrolizumab in first line locally advanced or metastatic urothelial carcinoma (la/mUC).
    Friedlander, Terence W.
    Milowsky, Matthew I.
    Bilen, Mehmet Asim
    Srinivas, Sandy
    Mckay, Rana R.
    Flaig, Thomas W.
    Hoimes, Christopher J.
    Balar, Arjun Vasant
    Henry, Elizabeth
    Petrylak, Daniel P.
    Sasse, Carolyn
    Kataria, Ritesh S.
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Avelumab first-line maintenance (1LM) for locally advanced or metastatic urothelial carcinoma (la/mUC): Treatment (tx) patterns and real-world (rw) outcomes in the US
    Carson, K.
    Mahmoudpour, H.
    Ike, C.
    Monzon, S.
    Fragkogianni, S.
    Ferrer, J.
    Kearney, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1215 - S1216
  • [48] Epidemiology and treatment patterns of patients with locally advanced or metastatic urothelial cancer in France: A non-interventional database study
    Lobbedez, F. Joly
    Roupret, M.
    Culine, S.
    Tricotel, A.
    Casarotto, E.
    Minacori, R.
    Strunz-McKendry, T.
    Karzazi, K.
    Leyland, K.
    Vuillet, M.
    Thomas, M-C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1157 - S1157
  • [49] Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma
    Geynisman, Daniel M.
    Handorf, Elizabeth
    Wong, Yu-Ning
    Doyle, Jamie
    Plimack, Elizabeth R.
    Horwitz, EricM.
    Canter, Daniel J.
    Uzzo, Robert G.
    Kutikov, Alexander
    Smaldone, Marc C.
    CANCER MEDICINE, 2016, 5 (02): : 192 - 199
  • [50] Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study.
    Duran, Miguel Angel A. Climent
    Perez-Gracia, Jose Luis
    Arija, Jose Angel Arranz
    Alvarez-Fernandez, Carlos
    Mediavilla, Jenifer Gomez
    Rodriguez, Angel
    Vazquez-Estevez, Sergio
    Jurado, Jose Miguel
    Santander, Carmen
    Bonfill, Teresa
    Palau, Carmen Molins
    Ramirez, Sara Perez
    Caceres, Paola Pimentel
    Arnaiz, Pablo
    Garate, Zita
    Soto, Atenea
    Puente, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345